GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for slowing Alzheimer’s — a disease with few treatment options.

Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

KING OF PRUSSIA, PA — Aclipse Therapeutics has entered a clinical collaboration with Mayo Clinic to advance a Phase 2 study ...

AbbVie is seeking European approval of expanded use of its migraine drug atogepant in adults following strong results from a ...

A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators ...

A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.

The links between neurons are crucial to the brain, and brain cells can reorganize they way they are linked together in a ...

Clinicians may fail to recognize common side effects of drugs like gabapentin - which are frequently prescribed for nerve pain - leading them to prescribe unnecessary medications that cause yet more ...

Researchers developed predictive models using routine clinical metrics to estimate pain modulation profiles in chronic pain.

Currently, most Parkinson’s treatments aim to replace lost dopamine or broadly stimulate brain regions to relieve symptoms.